UniProt ID | YTDC1_HUMAN | |
---|---|---|
UniProt AC | Q96MU7 | |
Protein Name | YTH domain-containing protein 1 {ECO:0000305} | |
Gene Name | YTHDC1 {ECO:0000312|HGNC:HGNC:30626} | |
Organism | Homo sapiens (Human). | |
Sequence Length | 727 | |
Subcellular Localization | Nucleus . Nucleus speckle . Localizes to a novel subnuclear structure, the YT bodies. | |
Protein Description | Regulator of alternative splicing that specifically recognizes and binds N6-methyladenosine (m6A)-containing RNAs. [PubMed: 26318451] | |
Protein Sequence | MAADSREEKDGELNVLDDILTEVPEQDDELYNPESEQDKNEKKGSKRKSDRMESTDTKRQKPSVHSRQLVSKPLSSSVSNNKRIVSTKGKSATEYKNEEYQRSERNKRLDADRKIRLSSSASREPYKNQPEKTCVRKRDPERRAKSPTPDGSERIGLEVDRRASRSSQSSKEEVNSEEYGSDHETGSSGSSDEQGNNTENEEEGVEEDVEEDEEVEEDAEEDEEVDEDGEEEEEEEEEEEEEEEEEEEEYEQDERDQKEEGNDYDTRSEASDSGSESVSFTDGSVRSGSGTDGSDEKKKERKRARGISPIVFDRSGSSASESYAGSEKKHEKLSSSVRAVRKDQTSKLKYVLQDARFFLIKSNNHENVSLAKAKGVWSTLPVNEKKLNLAFRSARSVILIFSVRESGKFQGFARLSSESHHGGSPIHWVLPAGMSAKMLGGVFKIDWICRRELPFTKSAHLTNPWNEHKPVKIGRDGQEIELECGTQLCLLFPPDESIDLYQVIHKMRHKRRMHSQPRSRGRPSRREPVRDVGRRRPEDYDIHNSRKKPRIDYPPEFHQRPGYLKDPRYQEVDRRFSGVRRDVFLNGSYNDYVREFHNMGPPPPWQGMPPYPGMEQPPHHPYYQHHAPPPQAHPPYSGHHPVPHEARYRDKRVHDYDMRVDDFLRRTQAVVSGRRSRPRERDRERERDRPRDNRRDRERDRGRDRERERERLCDRDRDRGERGRYRR | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
21 | Phosphorylation | NVLDDILTEVPEQDD CCHHHHHHHCCCCCC | 34.96 | 20873877 | |
31 | Phosphorylation | PEQDDELYNPESEQD CCCCCCCCCCCCCCC | 26.99 | 28122231 | |
35 | Phosphorylation | DELYNPESEQDKNEK CCCCCCCCCCCCCCC | 41.64 | 28387310 | |
48 | Acetylation | EKKGSKRKSDRMEST CCCCCHHHHHHHCCC | 61.52 | 12433863 | |
49 | Phosphorylation | KKGSKRKSDRMESTD CCCCHHHHHHHCCCC | 34.19 | 24719451 | |
54 | Phosphorylation | RKSDRMESTDTKRQK HHHHHHCCCCCCCCC | 23.41 | 30576142 | |
55 | Phosphorylation | KSDRMESTDTKRQKP HHHHHCCCCCCCCCC | 34.09 | 26074081 | |
57 | Phosphorylation | DRMESTDTKRQKPSV HHHCCCCCCCCCCCC | 28.37 | 26074081 | |
58 | Acetylation | RMESTDTKRQKPSVH HHCCCCCCCCCCCCC | 56.49 | 12433871 | |
71 | Phosphorylation | VHSRQLVSKPLSSSV CCHHHHHCCCCCCCC | 36.83 | 20068231 | |
72 | Acetylation | HSRQLVSKPLSSSVS CHHHHHCCCCCCCCC | 42.36 | 23954790 | |
75 | Phosphorylation | QLVSKPLSSSVSNNK HHHCCCCCCCCCCCC | 29.15 | 20068231 | |
76 | Phosphorylation | LVSKPLSSSVSNNKR HHCCCCCCCCCCCCC | 42.30 | 27732954 | |
77 | Phosphorylation | VSKPLSSSVSNNKRI HCCCCCCCCCCCCCE | 26.62 | 20068231 | |
79 | Phosphorylation | KPLSSSVSNNKRIVS CCCCCCCCCCCCEEE | 36.31 | 20068231 | |
82 | Acetylation | SSSVSNNKRIVSTKG CCCCCCCCCEEECCC | 47.99 | 25953088 | |
86 | Phosphorylation | SNNKRIVSTKGKSAT CCCCCEEECCCCCHH | 23.25 | 28655764 | |
95 | Phosphorylation | KGKSATEYKNEEYQR CCCCHHHHCCHHHHH | 18.11 | 27642862 | |
96 | Sumoylation | GKSATEYKNEEYQRS CCCHHHHCCHHHHHH | 52.21 | - | |
96 | Sumoylation | GKSATEYKNEEYQRS CCCHHHHCCHHHHHH | 52.21 | 28112733 | |
96 | Acetylation | GKSATEYKNEEYQRS CCCHHHHCCHHHHHH | 52.21 | 26051181 | |
100 | Phosphorylation | TEYKNEEYQRSERNK HHHCCHHHHHHHHHH | 11.75 | 27642862 | |
118 | Phosphorylation | ADRKIRLSSSASREP HHHHHCCCCCCCCCC | 16.64 | 30266825 | |
119 | Phosphorylation | DRKIRLSSSASREPY HHHHCCCCCCCCCCC | 34.22 | 27273156 | |
120 | Phosphorylation | RKIRLSSSASREPYK HHHCCCCCCCCCCCC | 27.21 | 23401153 | |
122 | Phosphorylation | IRLSSSASREPYKNQ HCCCCCCCCCCCCCC | 38.84 | 25159151 | |
126 | Phosphorylation | SSASREPYKNQPEKT CCCCCCCCCCCCCCC | 20.16 | 27273156 | |
132 | Acetylation | PYKNQPEKTCVRKRD CCCCCCCCCCCCCCC | 54.64 | 25953088 | |
146 | Phosphorylation | DPERRAKSPTPDGSE CHHHHCCCCCCCHHH | 32.78 | 29255136 | |
148 | Phosphorylation | ERRAKSPTPDGSERI HHHCCCCCCCHHHCC | 40.89 | 29255136 | |
152 | Phosphorylation | KSPTPDGSERIGLEV CCCCCCHHHCCCHHH | 30.96 | 30266825 | |
164 | Phosphorylation | LEVDRRASRSSQSSK HHHHHHHHCCCCCCH | 30.77 | 25159151 | |
264 | Phosphorylation | QKEEGNDYDTRSEAS HHHCCCCCCCCHHCC | 24.18 | 25850435 | |
266 | Phosphorylation | EEGNDYDTRSEASDS HCCCCCCCCHHCCCC | 29.84 | 25850435 | |
268 | Phosphorylation | GNDYDTRSEASDSGS CCCCCCCHHCCCCCC | 39.34 | 20873877 | |
271 | Phosphorylation | YDTRSEASDSGSESV CCCCHHCCCCCCCCE | 28.40 | 24905233 | |
273 | Phosphorylation | TRSEASDSGSESVSF CCHHCCCCCCCCEEE | 41.54 | 25849741 | |
275 | Phosphorylation | SEASDSGSESVSFTD HHCCCCCCCCEEECC | 30.56 | 25849741 | |
277 | Phosphorylation | ASDSGSESVSFTDGS CCCCCCCCEEECCCC | 25.43 | 25849741 | |
279 | Phosphorylation | DSGSESVSFTDGSVR CCCCCCEEECCCCCC | 31.54 | 24905233 | |
281 | Phosphorylation | GSESVSFTDGSVRSG CCCCEEECCCCCCCC | 31.76 | 24905233 | |
287 | Phosphorylation | FTDGSVRSGSGTDGS ECCCCCCCCCCCCCC | 34.84 | 28176443 | |
289 | Phosphorylation | DGSVRSGSGTDGSDE CCCCCCCCCCCCCHH | 39.50 | 24719451 | |
291 | Phosphorylation | SVRSGSGTDGSDEKK CCCCCCCCCCCHHHH | 38.59 | 28985074 | |
294 | Phosphorylation | SGSGTDGSDEKKKER CCCCCCCCHHHHHHH | 45.46 | 24719451 | |
308 | Phosphorylation | RKRARGISPIVFDRS HHHHCCCCCEEECCC | 16.05 | 19664994 | |
308 (in isoform 2) | Phosphorylation | - | 16.05 | 22115753 | |
315 | Phosphorylation | SPIVFDRSGSSASES CCEEECCCCCCCCCC | 44.89 | 25159151 | |
315 (in isoform 2) | Phosphorylation | - | 44.89 | 23663014 | |
317 | Phosphorylation | IVFDRSGSSASESYA EEECCCCCCCCCCCC | 24.79 | 25159151 | |
317 (in isoform 2) | Phosphorylation | - | 24.79 | 23663014 | |
318 | Phosphorylation | VFDRSGSSASESYAG EECCCCCCCCCCCCC | 39.06 | 25159151 | |
318 (in isoform 2) | Phosphorylation | - | 39.06 | 23663014 | |
320 | Phosphorylation | DRSGSSASESYAGSE CCCCCCCCCCCCCCH | 29.08 | 25159151 | |
320 (in isoform 2) | Phosphorylation | - | 29.08 | 26434776 | |
322 | Phosphorylation | SGSSASESYAGSEKK CCCCCCCCCCCCHHH | 20.14 | 22115753 | |
322 (in isoform 2) | Phosphorylation | - | 20.14 | 26434776 | |
323 | Phosphorylation | GSSASESYAGSEKKH CCCCCCCCCCCHHHH | 15.78 | 22115753 | |
323 (in isoform 2) | Phosphorylation | - | 15.78 | 26434776 | |
326 | Phosphorylation | ASESYAGSEKKHEKL CCCCCCCCHHHHHHH | 37.76 | 25159151 | |
327 (in isoform 2) | Phosphorylation | - | 66.27 | 26434776 | |
328 (in isoform 2) | Phosphorylation | - | 62.21 | 26434776 | |
334 | Phosphorylation | EKKHEKLSSSVRAVR HHHHHHHHHHHHHHH | 31.47 | 20068231 | |
335 | Phosphorylation | KKHEKLSSSVRAVRK HHHHHHHHHHHHHHC | 43.20 | 20068231 | |
336 | Phosphorylation | KHEKLSSSVRAVRKD HHHHHHHHHHHHHCC | 16.55 | 21815630 | |
345 | Phosphorylation | RAVRKDQTSKLKYVL HHHHCCCCCCHHHHH | 37.65 | 20068231 | |
346 | Phosphorylation | AVRKDQTSKLKYVLQ HHHCCCCCCHHHHHH | 30.29 | 20068231 | |
349 | Acetylation | KDQTSKLKYVLQDAR CCCCCCHHHHHHHCE | 36.73 | 25953088 | |
372 | Ubiquitination | HENVSLAKAKGVWST CCCEEEEEECCCEEC | 56.79 | - | |
372 | Acetylation | HENVSLAKAKGVWST CCCEEEEEECCCEEC | 56.79 | 25953088 | |
385 | Ubiquitination | STLPVNEKKLNLAFR ECCCCCHHHHHHHHH | 58.31 | - | |
385 | Acetylation | STLPVNEKKLNLAFR ECCCCCHHHHHHHHH | 58.31 | 25953088 | |
393 | Phosphorylation | KLNLAFRSARSVILI HHHHHHHHCCEEEEE | 22.91 | 20860994 | |
396 | O-linked_Glycosylation | LAFRSARSVILIFSV HHHHHCCEEEEEEEE | 17.15 | 30379171 | |
396 | Phosphorylation | LAFRSARSVILIFSV HHHHHCCEEEEEEEE | 17.15 | 20860994 | |
402 | Phosphorylation | RSVILIFSVRESGKF CEEEEEEEECCCCCC | 17.17 | 20860994 | |
406 | Phosphorylation | LIFSVRESGKFQGFA EEEEECCCCCCCCEE | 36.40 | 18669648 | |
408 | Acetylation | FSVRESGKFQGFARL EEECCCCCCCCEEEC | 43.74 | 25953088 | |
416 | Phosphorylation | FQGFARLSSESHHGG CCCEEECCCCCCCCC | 26.89 | 23401153 | |
417 | Phosphorylation | QGFARLSSESHHGGS CCEEECCCCCCCCCC | 47.94 | 22167270 | |
419 | Phosphorylation | FARLSSESHHGGSPI EEECCCCCCCCCCCC | 23.80 | 22167270 | |
424 | Phosphorylation | SESHHGGSPIHWVLP CCCCCCCCCCEEEEE | 25.85 | 22167270 | |
435 | Phosphorylation | WVLPAGMSAKMLGGV EEEECCCCHHHHCCE | 24.66 | 22167270 | |
469 | Sumoylation | TNPWNEHKPVKIGRD CCCCCCCCCEECCCC | 45.38 | - | |
469 | Sumoylation | TNPWNEHKPVKIGRD CCCCCCCCCEECCCC | 45.38 | - | |
469 | Ubiquitination | TNPWNEHKPVKIGRD CCCCCCCCCEECCCC | 45.38 | - | |
469 | Acetylation | TNPWNEHKPVKIGRD CCCCCCCCCEECCCC | 45.38 | 26051181 | |
472 | Ubiquitination | WNEHKPVKIGRDGQE CCCCCCEECCCCCCE | 48.23 | - | |
472 | Malonylation | WNEHKPVKIGRDGQE CCCCCCEECCCCCCE | 48.23 | 26320211 | |
497 | Phosphorylation | LLFPPDESIDLYQVI EECCCCCCCCHHHHH | 28.87 | 20068231 | |
515 | Phosphorylation | RHKRRMHSQPRSRGR HHHHHHCCCCCCCCC | 32.32 | 26846344 | |
519 | Phosphorylation | RMHSQPRSRGRPSRR HHCCCCCCCCCCCCC | 45.85 | 30576142 | |
524 | Phosphorylation | PRSRGRPSRREPVRD CCCCCCCCCCCCCCC | 42.48 | 28634120 | |
540 | Phosphorylation | GRRRPEDYDIHNSRK CCCCCCCCCCCCCCC | 18.35 | 28152594 | |
545 | Phosphorylation | EDYDIHNSRKKPRID CCCCCCCCCCCCCCC | 31.17 | 26055452 | |
553 | Phosphorylation | RKKPRIDYPPEFHQR CCCCCCCCCCHHHCC | 20.51 | 25884760 | |
563 | Phosphorylation | EFHQRPGYLKDPRYQ HHHCCCCCCCCCCHH | 17.17 | 28152594 | |
569 | Phosphorylation | GYLKDPRYQEVDRRF CCCCCCCHHHHHHHH | 17.89 | 27642862 | |
577 | Phosphorylation | QEVDRRFSGVRRDVF HHHHHHHCCCCCCEE | 34.27 | 29496963 | |
588 | Phosphorylation | RDVFLNGSYNDYVRE CCEECCCCHHHHHHH | 21.49 | 28450419 | |
656 | Phosphorylation | RDKRVHDYDMRVDDF CCCCCCCCCCCHHHH | 9.21 | - | |
667 | Phosphorylation | VDDFLRRTQAVVSGR HHHHHHHHHHHHCCC | 17.91 | 26074081 | |
672 | Phosphorylation | RRTQAVVSGRRSRPR HHHHHHHCCCCCCCC | 21.71 | 26074081 | |
676 | Phosphorylation | AVVSGRRSRPRERDR HHHCCCCCCCCHHHH | 45.32 | 26074081 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of YTDC1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of YTDC1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of YTDC1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ABL1_HUMAN | ABL1 | physical | 15175272 | |
RBY1F_HUMAN | RBMY1F | physical | 25416956 | |
KHDR2_HUMAN | KHDRBS2 | physical | 25416956 | |
SRC_HUMAN | SRC | physical | 15175272 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-308 AND SER-424, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-308; SER-315; SER-317;SER-318; SER-320 AND SER-424, AND MASS SPECTROMETRY. | |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-308, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-118; SER-308 ANDSER-577, AND MASS SPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-545, AND MASSSPECTROMETRY. | |
"Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-308, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-308, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-146; SER-308; SER-315;SER-317; SER-318; SER-320; SER-322; TYR-323; SER-326 AND SER-515, ANDMASS SPECTROMETRY. | |
"Global phosphoproteome of HT-29 human colon adenocarcinoma cells."; Kim J.-E., Tannenbaum S.R., White F.M.; J. Proteome Res. 4:1339-1346(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-146 AND THR-148, ANDMASS SPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-146; THR-148; SER-275;SER-308; SER-320 AND SER-326, AND MASS SPECTROMETRY. |